This division contracts the development, and supply of vaccines, antivirals, diagnostics, therapeutics and ancillary products for Pandemic Influenza, Project BioShield, and research and development Programs.  He is a contributing technical author to the Parenteral Drug Association publications and the International Society for Pharmaceutical Engineering (ISPE). Recently he worked with the Center for Disease Control in Sierra Leone on a Phase 2-3 Ebola vaccine clinical trial.  

Mr. Glauser has previously worked in line and staff positions with Pfizer (Wyeth) Pharmaceuticals in the Global Packaging Technology group supporting biotech, vaccine, and consumer areas with temperature controlled shipping expertise and solutions. In other industrial positions, he has directed supply chain, biological, sterile and chemical planning and manufacturing activities with Merck & Co. Inc. (25 years) and Fisher Clinical Services for in-line, new product and clinical biological and pharmaceutical entities both domestically and internationally.  A former US Navy officer and engineer, Mr. Glauser has a microbiology degree from Indiana University.